310 related articles for article (PubMed ID: 10914918)
21. Characterization of 3-[(123)I]iodo-L-alpha-methyl tyrosine transport in astrocytes of neonatal rats.
Kopka K; Riemann B; Friedrich M; Winters S; Halfter H; Weckesser M; Stögbauer F; Ringelstein EB; Schober O
J Neurochem; 2001 Jan; 76(1):97-104. PubMed ID: 11145982
[TBL] [Abstract][Full Text] [Related]
22. Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas.
Weber WA; Dick S; Reidl G; Dzewas B; Busch R; Feldmann HJ; Molls M; Lumenta CB; Schwaiger M; Grosu AL
J Nucl Med; 2001 Aug; 42(8):1144-50. PubMed ID: 11483672
[TBL] [Abstract][Full Text] [Related]
23. Intracellular reactions affecting 2-amino-4-([(11)C]methylthio)butyric acid ([(11)C]methionine) response to carbon ion radiotherapy in C10 glioma cells.
Uehara T; Nakagawa M; Takai N; Koike S; Furusawa Y; Ando K; Kawai K; Akizawa H; Irie T; Arano Y
Nucl Med Biol; 2009 Nov; 36(8):985-91. PubMed ID: 19875056
[TBL] [Abstract][Full Text] [Related]
24. Treatment-Related Uptake of
Geisler S; Stegmayr C; Niemitz N; Lohmann P; Rapp M; Stoffels G; Willuweit A; Galldiks N; Filss C; Sabel MC; Coenen HH; Shah NJ; Langen KJ
J Nucl Med; 2019 Oct; 60(10):1373-1379. PubMed ID: 30850492
[TBL] [Abstract][Full Text] [Related]
25. Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.
Lahoutte T; Caveliers V; Franken PR; Bossuyt A; Mertens J; Everaert H
J Nucl Med; 2002 Sep; 43(9):1201-6. PubMed ID: 12215559
[TBL] [Abstract][Full Text] [Related]
26. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
27. 3-[(123)I]Iodo-alpha-methyl-L-tyrosine: uptake mechanisms and clinical applications.
Langen KJ; Pauleit D; Coenen HH
Nucl Med Biol; 2002 Aug; 29(6):625-31. PubMed ID: 12234586
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the extension of cerebral gliomas by scintigraphy.
Weckesser M; Matheja P; Rickert C; Löttgen J; Palkovic S; Riemann B; Paulus W; Wassmann H; Schober O
Strahlenther Onkol; 2000 Apr; 176(4):180-5. PubMed ID: 10812391
[TBL] [Abstract][Full Text] [Related]
29. L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.
Jager PL; Groen HJ; van der Leest A; van Putten JW; Pieterman RM; de Vries EG; Piers DA
J Nucl Med; 2001 Apr; 42(4):579-85. PubMed ID: 11337545
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
31. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
[TBL] [Abstract][Full Text] [Related]
32. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K
Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701
[TBL] [Abstract][Full Text] [Related]
33. 3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.
Schmidt D; Gottwald U; Langen KJ; Weber F; Hertel A; Floeth F; Felsberg J; Reifenberger G; Coenen HH; Müller-Gärtner HW
Eur J Nucl Med; 2001 Jul; 28(7):855-61. PubMed ID: 11504082
[TBL] [Abstract][Full Text] [Related]
34. Amino acid PET tracers are reliable markers of treatment responses to single-agent or combination therapies including temozolomide, interferon-β, and/or bevacizumab for glioblastoma.
Ono T; Sasajima T; Doi Y; Oka S; Ono M; Kanagawa M; Baden A; Mizoi K; Shimizu H
Nucl Med Biol; 2015 Jul; 42(7):598-607. PubMed ID: 25892210
[TBL] [Abstract][Full Text] [Related]
35. Early effects of irradiation on [(123)I]-IMT and [(18)F]-FDG uptake in rat C6 glioma cells.
Riemann B; Könemann S; Pöpping D; Kopka K; Weckesser M; Willich N; Schober O
Strahlenther Onkol; 2004 Jul; 180(7):434-41. PubMed ID: 15241531
[TBL] [Abstract][Full Text] [Related]
36. Renal accumulation and excretion of radioiodinated 3-iodo-alpha-methyl-L-tyrosine.
Shikano N; Kawai K; Nakajima S; Nishii R; Flores LG; Kubodera A; Kubota N; Ishikawa N; Saji H
Ann Nucl Med; 2004 May; 18(3):263-70. PubMed ID: 15233289
[TBL] [Abstract][Full Text] [Related]
37. An artificial amino acid, 4-iodo-L-meta-tyrosine: biodistribution and excretion via kidney.
Shikano N; Kawai K; Flores LG; Nishii R; Kubota N; Ishikawa N; Kubodera A
J Nucl Med; 2003 Apr; 44(4):625-31. PubMed ID: 12679409
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine.
Kuwert T; Woesler B; Morgenroth C; Lerch H; Schäfers M; Palkovic S; Matheja P; Brandau W; Wassmann H; Schober O
J Nucl Med; 1998 Jan; 39(1):23-7. PubMed ID: 9443732
[TBL] [Abstract][Full Text] [Related]
39. Expression of L amino acid transport system 1 and analysis of iodine-123-methyltyrosine tumor uptake in a pancreatic xenotransplantation model using fused high-resolution-micro-SPECT-MRI.
von Forstner C; Zuhayra M; Ammerpohl O; Zhao Y; Tiwari S; Jansen O; Kalthoff H; Henze E; Egberts JH
Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):30-7. PubMed ID: 21269932
[TBL] [Abstract][Full Text] [Related]
40. Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity.
Jager PL; Plaat BE; de Vries EG; Molenaar WM; Vaalburg W; Piers DA; Hoekstra HJ
Clin Cancer Res; 2000 Jun; 6(6):2252-9. PubMed ID: 10873075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
